Jennison Associates
AGN.PRA

Jennison Associates’s Allergan plc AGN.PRA Stock Holding History

Jennison Associates’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-35,177
Closed -$20.6M – 723
2017
Q4 		$20.6M Sell
35,177
-33,905
-49% -$21.9M 0.02% 401
2017
Q3 		$51M Sell
69,082
-3,641
-5% -$3.02M 0.05% 268
2017
Q2 		$63.1M Buy
72,723
+2,814
+4% +$2.36M 0.07% 240
2017
Q1 		$59.3M Buy
69,909
+15,063
+27% +$12.5M 0.06% 237
2016
Q4 		$41.8M Buy
54,846
+153
+0.3% +$116K 0.05% 294
2016
Q3 		$44.9M Buy
54,693
+6,297
+13% +$5.44M 0.05% 292
2016
Q2 		$40.3M Buy
48,396
+20,925
+76% +$17.5M 0.04% 318
2016
Q1 		$25.3M Buy
27,471
+71
+0.3% +$67.9K 0.03% 382
2015
Q4 		$28.2M Buy
27,400
+19,900
+265% +$20M 0.03% 377
2015
Q3 		$7.08M Hold
7,500
– – 0.01% 526
2015
Q2 		$7.84M Buy
+7,500
New +$7.85M 0.01% 526

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Jennison Associates's AGN.PRA Position: Q1 2018 in Review

Jennison Associates sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 35,177 shares — an estimated $20.6M sold.

Jennison Associates first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $63.1M in Q2 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Jennison Associates reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Jennison Associates sold 35,177 Allergan plc shares in Q1 2018, an estimated $20.6M.
  • Jennison Associates first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Jennison Associates's Allergan plc position peaked at $63.1M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Jennison Associates's 13F filing for Q1 2018, filed 20 Apr 2018.